Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Open Access
- 7 April 2022
- journal article
- review article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 27 (6) , 2674-2688
Abstract
Early-onset Alzheimer’s disease (EOAD) is a rare but particularly devastating form of AD. Though notable for its high degree of clinical heterogeneity, EOAD is defined by the same neuropathological hallmarks underlying the more common, late-onset form of AD. In this review, we describe the various clinical syndromes associated with EOAD, including the typical amnestic phenotype as well as atypical variants affecting visuospatial, language, executive, behavioral, and motor functions. We go on to highlight advances in fluid biomarker research and describe how molecular, structural, and functional neuroimaging can be used not only to improve EOAD diagnostic acumen but also enhance our understanding of fundamental pathobiological changes occurring years (and even decades) before the onset of symptoms. In addition, we discuss genetic variation underlying EOAD, including pathogenic variants responsible for the well-known mendelian forms of EOAD as well as variants that may increase risk for the much more common forms of EOAD that are either considered to be sporadic or lack a clear autosomal-dominant inheritance pattern. Intriguingly, specific pathogenic variants inPRNPandMAPT—genes which are more commonly associated with other neurodegenerative diseases—may provide unexpectedly important insights into the formation of AD tau pathology. Genetic analysis of the atypical clinical syndromes associated with EOAD will continue to be challenging given their rarity, but integration of fluid biomarker data, multimodal imaging, and various ‘omics techniques and their application to the study of large, multicenter cohorts will enable future discoveries of fundamental mechanisms underlying the development of EOAD and its varied clinical presentations.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Aging (AG062588, AG057234, AG062422, AG065501)
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS123985)
- U.S. Department of Health & Human Services | NIH | National Institute on Aging
This publication has 242 references indexed in Scilit:
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseNew England Journal of Medicine, 2012
- Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's diseaseNeurobiology of Aging, 2012
- Autosomal Recessive Causes Likely in Early-Onset Alzheimer DiseaseArchives of Neurology, 2012
- A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer diseaseEuropean Journal of Human Genetics, 2011
- Association of TMEM106B Gene Polymorphism With Age at Onset in Granulin Mutation Carriers and Plasma Granulin Protein LevelsArchives of Neurology, 2011
- Familial prion disease with alzheimer disease‐like tau pathology and clinical phenotypeAnnals of Neurology, 2011
- Clinicopathological correlations in corticobasal degenerationAnnals of Neurology, 2011
- Evidence for three loci modifying age‐at‐onset of Alzheimer's disease in early‐onset PSEN2 familiesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2010
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsNature Genetics, 2010
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991